Limbix is actively creating prescription digital therapeutics (PDTs) to enable doctors to prescribe digital, evidence-based, therapeutic interventions for adolescent mental health. 

PDTs require strict compliance with FDA quality management standards and are validated through rigorous clinical trials. Upon FDA clearance, PDTs can be prescribed by a doctor to treat specific medical conditions.